Viral Infections Drive Up Medicine Sales

Ahmedabad: The rise in viral infections across the state in June and July led to a corresponding rise in medicine sales. According to data by Pharmarack, the sale of drugs for anti-infective therapy grew by 22% in June-July 2024, whereas those for respiratory ailments went up by 20% compared to the corresponding period last year. The sales of analgesics have also gone up given an increase in cases of fever and body ache.

Heavy rainfall and drastic temperature differences led to a rise in the prevalence of infections, allergies, viral fevers and upper respiratory ailments among people. Antibiotics and medicines for respiratory illnesses are some of the commonly administered drugs to treat these symptoms, resulting in an increase in their sales.

In Gujarat, Rs 90 crore worth of drugs for treating respiratory illnesses such as flu and cough were retailed across the state in June-July this year compared to Rs 75 crore during the same period last year. Similarly, anti-infective medicines worth Rs 168 crore were retailed in the state from Rs 139 crore during the same period last year, according to Pharmarack’s data.

Explaining the trend, Alpesh Patel, chairperson, Federation of Gujarat State Chemists and Druggists’ Association (FGSCDA), said, “The cases of seasonal viral infections saw a sharp rise in the past couple of months. Changing rainfall patterns led to an increase in these infections along with respiratory ailments like cough and throat infections.”

Dr Pravin Garg, a physician, said, “It is clinically difficult to differentiate between viral fever, swine flu and dengue fever. We advise citizens to increase their liquid intake,” he said.

Dr Dhiren Mehta, a physician, “It is okay to have paracetamol for symptomatic treatment , but do not take antibiotics without medical advice.”

Related Posts

English alphabets can’t be trademarked: Delhi HC

New Delhi: The Delhi High Court recently held that English alphabets cannot be monopolised through trademark law and refused interim protection to the mark ‘A TO Z’ used by a pharmaceutical…

IIT Roorkee develops next-generation antibody discovery platform

Dehradun: In a significant step towards affordable healthcare, pandemic preparedness, and indigenous biotechnology innovation, the Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

English alphabets can’t be trademarked: Delhi HC

English alphabets can’t be trademarked: Delhi HC

IIT Roorkee develops next-generation antibody discovery platform

IIT Roorkee develops next-generation antibody discovery platform

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

Spiralling Gold And Silver Prices Impact Costs Of Ayurvedic Medicines With Traces Of Precious Metals

Spiralling Gold And Silver Prices Impact Costs Of Ayurvedic Medicines With Traces Of Precious Metals

Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park

Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park

CDSCO to dispose online applications pending for more than two years

CDSCO to dispose online applications pending for more than two years